In fact, GSEA demonstrated that EDA2R activation and tumour inoculation led to similar expression patterns in muscle cells, including the stimulation of NFκB, JAK–STAT and TGFβ pathways and the suppression of myogenesis, oxidative phosphorylation and fatty acid oxidation. The gene discussed is TGFB1; the disease is neoplasm.